Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,155 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07703345Recruiting
Saliva markers in people with diabetes and gum disease
This study checks whether certain substances in saliva can help detect gum disease in people with type 2 diabetes. It compares the levels of these substances in people with diabetes and gum disease, people with gum disease only, people with diabetes only, and healthy volunteers.
Konya, KonyaAges 18–80 - NCT06650969Recruiting
Early detection of cognitive decline in type 2 diabetes
This study is looking at ways to catch early thinking and memory changes in people with type 2 diabetes. By joining, you may help doctors learn how to spot problems sooner and find better ways to help.
Nanjing, JiangsuAges 45 years+ - NCT06384313Recruiting
Butyrate supplement for preventing diabetes
This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.
Maastricht, LimburgAges 20–70 - NCT07688694Enrolling by invitation
Testing a legume-based supplement for blood sugar control
This study tests a supplement made from legume seed coats that may help control blood sugar. It is open to healthy adults, people at risk for diabetes, or those already diagnosed with type 2 diabetes.
Mysore, KarnatakaAges 20–60 - NCT07675551Recruiting
Diabetes prevention program for Peel families
This program helps family caregivers in the Peel Region who are at risk for diabetes learn healthy habits (like diet and exercise) to prevent the condition. It's designed for South Asian and Black, African, or Caribbean families with children at home.
Brampton, OntarioAges 14 years+ - NCT07661368Recruiting
Healthy cooking to prevent dementia and diabetes
This study tests whether learning to cook healthy meals can help prevent dementia and diabetes. You'll be asked to follow a cooking program and use your smartphone to track progress.
Blacksburg, VirginiaAges 50–75 - NCT07654374RecruitingPhase 3
Study of a new pill for weight loss and diabetes
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
Birmingham, AlabamaAges 18–79 - NCT07646678RecruitingPhase 2/Phase 3
TAK-360 Extension Study for Narcolepsy or Excessive Sleepiness
This is a follow-up study for people who already completed a TAK-360 trial for narcolepsy (a sleep disorder causing sudden sleep attacks) or idiopathic hypersomnia (excessive daytime sleepiness). Researchers want to see if continuing TAK-360 remains safe and effective for you.
Chula Vista, CaliforniaAges 18–71 - NCT06214520Recruiting
App and AI support for managing type 2 diabetes
This trial tests whether a smartphone app and smartwatch can help you better manage your type 2 diabetes. You'll get motivational support and an AI coach to guide your care.
SingaporeAges 21–100 - NCT07641309Recruiting
Health Program for Diabetes, Lung, or Heart Disease
This study measures how a health improvement program helps people with type 2 diabetes, chronic lung disease, or heart disease. Researchers will track your health before and after you participate in the program offered by your local municipality.
FrederiksværkAges 18 years+ - NCT07614230RecruitingPhase 4
SGLT2 drugs and heart artery health in diabetes
This study tests whether a diabetes medication called SGLT2 inhibitors can slow the buildup of plaque in heart arteries. Researchers will use special CT scans to track changes in your coronary arteries over time.
Beijing, Beijing MunicipalityAges 18–78 - NCT07619157RecruitingPhase 1
ONO-3310 Study for Kidney Disease and Type 2 Diabetes
This early-stage trial tests a new drug called ONO-3310 in two groups: healthy adults and people with kidney disease caused by type 2 diabetes. The study aims to understand how the drug works and whether it might help protect kidney function in people with diabetes.
Fukuoka, FukuokaAges 18–64 - NCT07608055Recruiting
Pancreas Removal and Metabolic Health in Non-Diabetic Patients
This study follows patients who are having part or all of their pancreas removed due to disease. Researchers want to understand how this surgery affects blood sugar control, weight, and overall health in people without diabetes before surgery.
RomeAges 18 years+ - NCT07598708RecruitingPhase 2/Phase 3
Cleminorexton for Narcolepsy: A New Treatment Study
This study tests whether a new medication called cleminorexton helps people with narcolepsy (a condition causing severe daytime sleepiness) sleep better and feel more alert. You would take this medication instead of your current narcolepsy drugs for several months to see if it works.
Birmingham, AlabamaAges 18–70 - NCT07583355Recruiting
Team-Based Counseling to Help Diabetes and Activity
This study tests whether meeting with a team of healthcare providers helps people with type 2 diabetes become more physically active and manage their condition better. You'll receive personalized guidance on exercise and diabetes care.
Perugia, PGAges 25–80 - NCT07574138Recruiting
How Beta Cells Work in Early-Onset Type 2 Diabetes
This study examines how insulin-producing cells (beta cells) function in people diagnosed with type 2 diabetes before age 40. Understanding these differences may help doctors develop better treatments for younger patients.
Ho Chi Minh City, Cho Lon WardAges Any age - NCT07566845Enrolling by invitation
High-intensity exercise for women after gestational diabetes
This study tests whether high-intensity interval training (HIIT)—short bursts of intense exercise—can help women who had gestational diabetes during pregnancy stay healthy and prevent type 2 diabetes. You'll do supervised workouts over several months while researchers track your health.
Odense, Region SyddanmarkAges 25–45 - NCT07559188Recruiting
A contact lens for presbyopia and keratoconus
This trial tests a special contact lens that uses a tiny opening to improve vision for people with presbyopia (age-related reading blur) or with keratoconus (a cone-shaped cornea). The lens aims to make both near and distant objects clearer without surgery.
AntwerpAges 18 years+ - NCT07554443Recruiting
Wearable Device to Improve Balance and Walking in Older Adults
This study tests a wearable device called Walkasins that uses gentle vibrations on your foot to help improve balance and walking ability. It's designed for older adults with nerve damage in their feet who have difficulty with balance.
Jacksonville, FloridaAges 60 years+ - NCT06739135Recruiting
Driving with diabetic neuropathy study
This study looks at how diabetic neuropathy (nerve damage from diabetes) affects driving safety. You may join if you have type 2 diabetes with or without neuropathy and are an experienced driver in the UK.
ManchesterAges 25–69 - NCT07544407Enrolling by invitation
Text-Based Diabetes Support for Parents
This study helps parents newly diagnosed with type 2 diabetes learn to manage their condition while caring for young children. You'll receive text messages and join virtual sessions designed to support both your health and your family.
Pleasanton, CaliforniaAges 21–44 - NCT07549373Recruiting
Laser and natural treatments for tooth root infections in diabetics
This study tests whether diode laser (a type of focused light), gudmar (an herbal supplement), and vinegar can help treat tooth infections during root canal therapy in people with type 2 diabetes. The goal is to see if these treatments reduce infection and improve healing.
Noida, Uttar PradeshAges 25–60 - NCT07506356Recruiting
Stomach emptying in diabetes patients on GLP-1 drugs
This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.
Geneva, Canton of GenevaAges 18 years+ - NCT07482072Recruiting
Brain blood flow and sugar study for Alzheimer's and diabetes
This study uses brain scans to see how blood flow and sugar transport work in people with both Alzheimer's disease and type 2 diabetes. It may help doctors understand how these conditions interact and find better treatments.
HerlevAges 60–90
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,155 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.